ALLK · Allakos Inc
Acquired Company
Concentra Biosciences acquired Allakos for $0.33 per share in cash, with the merger closing on May 15, 2025.
As of May 15, 2025, operates as a subsidiary of Concentra Biosciences, LLC.
Market Cap
29.74M
52 Wk Range
$0.22 - $1.55
Previous Close
$0.33
Open
$0.33
Volume
N/A
Day Range
$0.33 - $0.33
Enterprise Value
-25.49M
Cash
55.24M
Avg Qtr Burn
N/A
Insider Ownership
1.96%
Institutional Own.
76.72%
Qtr Updated
Mar 31st 2025